파로스아이바이오

388870KOSDAQSector: Pharma & Biotech

₩4,980▼ 1.58%Market cap ₩64.5BAs of Jul 21, 2026 close · updated once daily

Grade D32.6 ptsTop 82% of 2,523 stocks

Financial strength

41.7

Price attractiveness

22.2

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

ⓘ Growth momentum not rated — will be included automatically as data accumulates

Financial strength

41.7

How much debt does it carry relative to equity?

Debt-to-equity ratio

114.5%

✗ Below median · Top 81.1% in sector

Sector median 51.5%

Can it cover what's due within a year?

Current ratio

1895.8%

✓ Above median · Top 4.7% in sector

Sector median 191.3%

How much did it earn on its own capital?

ROE (return on equity)

-76.8%

✗ Below median · Top 89.2% in sector

Sector median -4.5%

Source filing: annual report (consolidated) — view original ↗

Growth momentum

Did core profits grow in a year?

Operating income change (YoY)

8.7%

✓ Above median · Top 46.2% in sector

Sector median 3.6%

Source filing: annual report (consolidated) — view original ↗

Price attractiveness

22.2

Is the price expensive relative to earnings?

P/E (price-to-earnings)

Loss-making (P/E not computable)

✗ Below median · Top 80.3% in sector

Sector median P/E of profitable peers 14.4x · 57% loss-making

Is the price expensive relative to book value?

P/B (price-to-book)

4.63x

✗ Below median · Top 75.4% in sector

Sector median 1.39x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 248 stocks in Pharma & Biotech

S1A52B66C51D61F15